Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Sanofi (SNY) Equity Average (2016 - 2025)

Sanofi's Equity Average history spans 9 years, with the latest figure at $83.0 billion for Q4 2025.

  • For Q4 2025, Equity Average rose 2.11% year-over-year to $83.0 billion; the TTM value through Dec 2025 reached $83.0 billion, up 2.11%, while the annual FY2025 figure was $82.3 billion, 0.34% changed from the prior year.
  • Equity Average for Q4 2025 was $83.0 billion at Sanofi, up from $81.2 billion in the prior quarter.
  • Across five years, Equity Average topped out at $83.0 billion in Q4 2025 and bottomed at $76.9 billion in Q4 2021.
  • The 5-year median for Equity Average is $78.0 billion (2023), against an average of $79.3 billion.
  • The largest annual shift saw Equity Average grew 9.39% in 2021 before it grew 0.69% in 2022.
  • A 5-year view of Equity Average shows it stood at $76.9 billion in 2021, then increased by 0.69% to $77.4 billion in 2022, then grew by 0.71% to $78.0 billion in 2023, then grew by 4.18% to $81.2 billion in 2024, then increased by 2.11% to $83.0 billion in 2025.
  • Per Business Quant, the three most recent readings for SNY's Equity Average are $83.0 billion (Q4 2025), $81.2 billion (Q4 2024), and $78.0 billion (Q4 2023).